PTC Therapeutics News
Most Popular PTC Therapeutics Story
PTC's lead drug ataluren flunks PhIIb
PTC Therapeutics' lead drug ataluren failed a Phase IIb trial, flunking a test of its ability to improve the physical performance of patients with a rare genetic disorder. Genzyme is partnered on the Read more...
Latest Headlines
- January 4, 2012
- November 29, 2011
- September 2, 2011
- June 29, 2011
- March 3, 2010
- February 24, 2010
- February 1, 2010
- December 22, 2009
- September 2, 2009
- August 21, 2008
- July 18, 2008
- July 17, 2008
- July 16, 2008
- September 13, 2007
Paid Research Reports
- Trends in mHealth and Telemedicine
- The Global Aesthetic Dermatology Market Outlook
- Future Directions in Regenerative Medicine
- Pipeline Insight: Insulin Antidiabetics – Novel analogs show promise as alternative delivery methods prove less attractive
- Pipeline Insight: Non-insulin Antidiabetics - Rise of the weight-reducers: Once-weekly GLP-1 agonists and novel SGLT-2 inhibitor
- Forecast Insight: Antidiabetics - Diabetes market growth driven by epidemiological trends and rich pipeline
